Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables BLOOD Roberts, A. W., Ma, S., Kipps, T. J., Coutre, S. E., Davids, M. S., Eichhorst, B., Hallek, M., Byrd, J. C., Humphrey, K., Zhou, L., Chyla, B., Nielsen, J., Potluri, J., Kim, S., Verdugo, M., Stilgenbauer, S., Wierda, W. G., Seymour, J. F. 2019; 134 (2): 111–22

View details for DOI 10.1182/blood.2018882555

View details for Web of Science ID 000474864100008